Viewing Study NCT06440993


Ignite Creation Date: 2025-12-25 @ 12:56 AM
Ignite Modification Date: 2026-04-23 @ 11:25 PM
Study NCT ID: NCT06440993
Status: RECRUITING
Last Update Posted: 2025-12-01
First Post: 2024-05-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Extrahepatic Cholangiocarcinoma View
None Unresectable Perihilar or Ductal CCA View
Keywords: